A growing body of evidence suggests that TARC plays a role in several inflammatory skin diseases including AD, psoriasis and mycosis fungoides (a cutaneous T-cell lymphoma)34–36. Here, CCL17 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.